Radiation before and after surgery for adults with soft tissue sarcoma
Tests radiation before surgery, then surgery, then radiation, in adults with soft tissue sarcoma.
Plain-language title generated from the registry record
Registry title: Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy and Postoperative Conformal Radiation Therapy
Key facts
- Where
- Saint Petersburg, RussiaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT04330456, who can take part
Where in Russia
- National Research Center of Oncology named after N.N.PetrovSaint Petersburg, RussiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- N.N. Petrov National Medical Research Center of Oncology
- Trial code
- NCT04330456
- Record updated
- 1 April 2020
- Original description
Combined treatment of soft tissue sarcoma includes 3 steps:Read full original descriptionShow less
Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy and Postoperative Conformal Radiation Therapy
Combined treatment of soft tissue sarcoma includes 3 steps:
1. step - preoperative stereotactic radiation therapy in hypofractionation mode 2. step - operation 3. step - postoperative conformal radiation therapy in normofractionation mode
Inclusion: morphologically verified diagnosis of soft tissue sarcoma; first diagnosed tumor process; ability to perform radical surgery; signed informed consent; indications for stereotactic and conformal radiation therapy; no contraindications for radiation and surgical treatment.
Exclusion: previous radiation treatment; tumor topography and volume that don't allow to perform stereotactic and conformal radiation therapy; acute infection; conditions that can affect the outcome of treatment (immunodeficiency, tuberculosis, etc.); pregnancy, lactation; recurrent tumor; refuse to sign informed consent.